Page last updated: 2024-11-02

pamidronate and Acropachy, Hereditary

pamidronate has been researched along with Acropachy, Hereditary in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Some patients with primary hypertrophic osteoarthropathy display an interesting palindrome."2.44Hypertrophic osteoarthropathy: a palindrome with a pathogenic connotation. ( Martinez-Lavin, M; Rivera-Viñas, M; Vargas, A, 2008)
"Pachydermoperiostosis is manifested by finger clubbing, hypertrophic skin changes, and periosteal bone formation."1.31Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. ( Chastanet, P; Cortet, B; Cotten, A; Delcambre, B; Deprez, X; Flipo, RM; Guyot-Drouot, MH; Solau-Gervais, E, 2000)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhansali, A1
Singh, R1
Sriraam, M1
Bhadada, S1
Martinez-Lavin, M1
Vargas, A1
Rivera-Viñas, M1
Guyot-Drouot, MH1
Solau-Gervais, E1
Cortet, B1
Deprez, X1
Chastanet, P1
Cotten, A1
Delcambre, B1
Flipo, RM1

Reviews

1 review available for pamidronate and Acropachy, Hereditary

ArticleYear
Hypertrophic osteoarthropathy: a palindrome with a pathogenic connotation.
    Current opinion in rheumatology, 2008, Volume: 20, Issue:1

    Topics: Bone Density Conservation Agents; Crohn Disease; Diphosphonates; Ductus Arteriosus, Patent; Humans;

2008

Other Studies

2 other studies available for pamidronate and Acropachy, Hereditary

ArticleYear
Pachydermoperiostitis and bisphosphonates.
    The Journal of the Association of Physicians of India, 2006, Volume: 54

    Topics: Adolescent; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Disease Progression;

2006
Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates.
    The Journal of rheumatology, 2000, Volume: 27, Issue:10

    Topics: Adult; Aged; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Humans; Injections, Intravenous;

2000